Practice-related improvement in information processing with novel antipsychotic treatment

Philip D Harvey, Patrick J. Moriarty, Mark R. Serper, Elke Schnur, Dana Lieber

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Background: Attentional deficits are prominent in schizophrenia, and skill learning is impaired. Novel antipsychotic treatment has been reported to improve certain cognitive skills in schizophrenic patients, but no information is yet available about the effect of newer medications on skill learning. Methods: Clinically stable patients with schizophrenia (n=16) and chronically hospitalized inpatients (n=8) were recruited while receiving conventional antipsychotic treatment. Subjects were tested at baseline on a visual continuous performance test (CPT), performed alone and simultaneously with an auditory CPT. Normal controls (n=8) were also tested at baseline. The inpatients and half of the outpatients were switched to treatment with risperidone. All patients then performed the visual CPT on a daily basis and performed the dual tasks once per week, for 4weeks. Results: Patients who remained on conventional medications did not improve in their performance despite the extensive practice on the test. Both chronic and stable patients receiving risperidone treatment manifested a statistically significant (P<0.05) improvement from baseline on both single and dual-task visual CPT. Stable outpatients performed significantly better at the end of the protocol than the normal controls performance at baseline (P<0.05). Implications: These results suggest that practice-related improvements in the performance of information processing tests are enhanced by novel antipsychotic medications. Although the specific biological mechanism of this effect is not yet known, the results may suggest that use of newer medications will enhance skill development and perhaps facilitate rehabilitation of patients with schizophrenia. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalSchizophrenia Research
Volume46
Issue number2-3
DOIs
StatePublished - Dec 15 2000
Externally publishedYes

Fingerprint

Automatic Data Processing
Antipsychotic Agents
Schizophrenia
Risperidone
Inpatients
Outpatients
Therapeutics
Learning
Rehabilitation

Keywords

  • Attentional deficits
  • Information processing
  • Novel antipsychotics
  • Practice-related improvement
  • Schizophrenia
  • Skill development

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Practice-related improvement in information processing with novel antipsychotic treatment. / Harvey, Philip D; Moriarty, Patrick J.; Serper, Mark R.; Schnur, Elke; Lieber, Dana.

In: Schizophrenia Research, Vol. 46, No. 2-3, 15.12.2000, p. 139-148.

Research output: Contribution to journalArticle

Harvey, Philip D ; Moriarty, Patrick J. ; Serper, Mark R. ; Schnur, Elke ; Lieber, Dana. / Practice-related improvement in information processing with novel antipsychotic treatment. In: Schizophrenia Research. 2000 ; Vol. 46, No. 2-3. pp. 139-148.
@article{41d2725335b74ec88d22e3b94c7ebc42,
title = "Practice-related improvement in information processing with novel antipsychotic treatment",
abstract = "Background: Attentional deficits are prominent in schizophrenia, and skill learning is impaired. Novel antipsychotic treatment has been reported to improve certain cognitive skills in schizophrenic patients, but no information is yet available about the effect of newer medications on skill learning. Methods: Clinically stable patients with schizophrenia (n=16) and chronically hospitalized inpatients (n=8) were recruited while receiving conventional antipsychotic treatment. Subjects were tested at baseline on a visual continuous performance test (CPT), performed alone and simultaneously with an auditory CPT. Normal controls (n=8) were also tested at baseline. The inpatients and half of the outpatients were switched to treatment with risperidone. All patients then performed the visual CPT on a daily basis and performed the dual tasks once per week, for 4weeks. Results: Patients who remained on conventional medications did not improve in their performance despite the extensive practice on the test. Both chronic and stable patients receiving risperidone treatment manifested a statistically significant (P<0.05) improvement from baseline on both single and dual-task visual CPT. Stable outpatients performed significantly better at the end of the protocol than the normal controls performance at baseline (P<0.05). Implications: These results suggest that practice-related improvements in the performance of information processing tests are enhanced by novel antipsychotic medications. Although the specific biological mechanism of this effect is not yet known, the results may suggest that use of newer medications will enhance skill development and perhaps facilitate rehabilitation of patients with schizophrenia. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Attentional deficits, Information processing, Novel antipsychotics, Practice-related improvement, Schizophrenia, Skill development",
author = "Harvey, {Philip D} and Moriarty, {Patrick J.} and Serper, {Mark R.} and Elke Schnur and Dana Lieber",
year = "2000",
month = "12",
day = "15",
doi = "10.1016/S0920-9964(00)00033-5",
language = "English",
volume = "46",
pages = "139--148",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Practice-related improvement in information processing with novel antipsychotic treatment

AU - Harvey, Philip D

AU - Moriarty, Patrick J.

AU - Serper, Mark R.

AU - Schnur, Elke

AU - Lieber, Dana

PY - 2000/12/15

Y1 - 2000/12/15

N2 - Background: Attentional deficits are prominent in schizophrenia, and skill learning is impaired. Novel antipsychotic treatment has been reported to improve certain cognitive skills in schizophrenic patients, but no information is yet available about the effect of newer medications on skill learning. Methods: Clinically stable patients with schizophrenia (n=16) and chronically hospitalized inpatients (n=8) were recruited while receiving conventional antipsychotic treatment. Subjects were tested at baseline on a visual continuous performance test (CPT), performed alone and simultaneously with an auditory CPT. Normal controls (n=8) were also tested at baseline. The inpatients and half of the outpatients were switched to treatment with risperidone. All patients then performed the visual CPT on a daily basis and performed the dual tasks once per week, for 4weeks. Results: Patients who remained on conventional medications did not improve in their performance despite the extensive practice on the test. Both chronic and stable patients receiving risperidone treatment manifested a statistically significant (P<0.05) improvement from baseline on both single and dual-task visual CPT. Stable outpatients performed significantly better at the end of the protocol than the normal controls performance at baseline (P<0.05). Implications: These results suggest that practice-related improvements in the performance of information processing tests are enhanced by novel antipsychotic medications. Although the specific biological mechanism of this effect is not yet known, the results may suggest that use of newer medications will enhance skill development and perhaps facilitate rehabilitation of patients with schizophrenia. Copyright (C) 2000 Elsevier Science B.V.

AB - Background: Attentional deficits are prominent in schizophrenia, and skill learning is impaired. Novel antipsychotic treatment has been reported to improve certain cognitive skills in schizophrenic patients, but no information is yet available about the effect of newer medications on skill learning. Methods: Clinically stable patients with schizophrenia (n=16) and chronically hospitalized inpatients (n=8) were recruited while receiving conventional antipsychotic treatment. Subjects were tested at baseline on a visual continuous performance test (CPT), performed alone and simultaneously with an auditory CPT. Normal controls (n=8) were also tested at baseline. The inpatients and half of the outpatients were switched to treatment with risperidone. All patients then performed the visual CPT on a daily basis and performed the dual tasks once per week, for 4weeks. Results: Patients who remained on conventional medications did not improve in their performance despite the extensive practice on the test. Both chronic and stable patients receiving risperidone treatment manifested a statistically significant (P<0.05) improvement from baseline on both single and dual-task visual CPT. Stable outpatients performed significantly better at the end of the protocol than the normal controls performance at baseline (P<0.05). Implications: These results suggest that practice-related improvements in the performance of information processing tests are enhanced by novel antipsychotic medications. Although the specific biological mechanism of this effect is not yet known, the results may suggest that use of newer medications will enhance skill development and perhaps facilitate rehabilitation of patients with schizophrenia. Copyright (C) 2000 Elsevier Science B.V.

KW - Attentional deficits

KW - Information processing

KW - Novel antipsychotics

KW - Practice-related improvement

KW - Schizophrenia

KW - Skill development

UR - http://www.scopus.com/inward/record.url?scp=0034670602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034670602&partnerID=8YFLogxK

U2 - 10.1016/S0920-9964(00)00033-5

DO - 10.1016/S0920-9964(00)00033-5

M3 - Article

C2 - 11120426

AN - SCOPUS:0034670602

VL - 46

SP - 139

EP - 148

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2-3

ER -